Generic Dimenhydrinate Injection USP for Motion Sickness [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2004-08-26 16:29  – Posting: # 8
Views: 11,354

The FDA approved on 24 June 2004 a new generic of dimenhydrinate (dimenhydrinate injection USP, made by American Pharmaceutical Partners, Inc.), an antiemetic indicated for the prevention and treatment of nausea, vomiting, or vertigo of motion sickness. It is the generic equivalent of Dramamine (made by Pfizer) and will be available in 50 mg/mL, 1 mL vials.

Manufacturing of dimenhydrinate injection had been discontinued since 2000 for reasons other than safety or efficacy.

Medscape members may follow this link:
http://www.medscape.com/viewarticle/482387

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,810 posts in 4,198 threads, 1,360 registered users;
online 11 (3 registered, 8 guests [including 5 identified bots]).
Forum time (Europe/Vienna): 07:52 CEST

A big computer, a complex algorithm and a long time
does not equal science.    Robert Gentleman

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5